Literature DB >> 8700133

Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.

H E Melikian1, S Ramamoorthy, C G Tate, R D Blakely.   

Abstract

The role of N-glycosylation in the expression, stability, and ligand recognition by the cocaine- and antidepressant-sensitive human norepinephrine transporter (hNET) was assessed in stably and transiently transfected cell lines. The use of hNET-specific antibodies and the membrane-impermeant biotinylating reagent sulfosuccinimidobiotin establishes that treatment of stably transfected LLC-PK1 cells with tunicamycin depletes surface membranes of mature hNET glycoproteins, which is consistent with a failure of less stable, nonglycosylated subunits to replenish surface compartments. To determine whether N-glycosylation plays a direct role in hNET stability, surface expression, and ligand recognition, we mutated the three hNET canonical N-glycosylation sites (hNETN184, 192, 198Q) and transiently expressed the mutant cDNA in parallel with the parental hNET construct in HeLa and COS cells. hNETN184, 192, 198Q protein exhibited increased electrophoretic mobility (approximately 46 kDa), similar to that of enzymatically N-deglycosylated hNET protein, which confirms the use of canonical sites in the second extracellular loop of the transporter. hNETN184, 192, 198Q protein in HeLa and COS extracts was reduced approximately 50% relative to hNET protein in parallel transfections, demonstrated to arise from a reduction in transporter half-life, which is consistent with the proposed role of N-glycosylation in hNET stability. Both HeLa and COS cells transfected with hNETN184, 192, 198Q exhibit a significantly greater reduction in transport activity than can be accounted for by losses in either total or surface NET protein. Furthermore, sensitivity of catecholamine transport to unlabeled substrate and antagonists was unchanged in the mutant, suggesting that residual nonglycosylated surface hNETs execute a key step in the transport cycle after ligand recognition with reduced efficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700133

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  27 in total

1.  Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A.

Authors:  A L Bauman; S Apparsundaram; S Ramamoorthy; B E Wadzinski; R A Vaughan; R D Blakely
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 2.  Glycosylation of solute carriers: mechanisms and functional consequences.

Authors:  Nis Borbye Pedersen; Michael C Carlsson; Stine Falsig Pedersen
Journal:  Pflugers Arch       Date:  2015-09-18       Impact factor: 3.657

3.  N-glycosylation in regulation of the nervous system.

Authors:  Hilary Scott; Vladislav M Panin
Journal:  Adv Neurobiol       Date:  2014

4.  A variant of the bovine noradrenaline transporter reveals the importance of the C-terminal region for correct targeting to the membrane and functional expression.

Authors:  L D Burton; A G Kippenberger; B Lingen; M Brüss; H Bönisch; D L Christie
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  Hibernating myocardium results in partial sympathetic denervation and nerve sprouting.

Authors:  Stanley F Fernandez; Vladislav Ovchinnikov; John M Canty; James A Fallavollita
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-02       Impact factor: 4.733

6.  Nicotine increases dopamine transporter function in rat striatum through a trafficking-independent mechanism.

Authors:  Lisa S Middleton; Subbu Apparsundaram; Kelley A King-Pospisil; Linda P Dwoskin
Journal:  Eur J Pharmacol       Date:  2006-10-19       Impact factor: 4.432

7.  Comparative modeling of the human monoamine transporters: similarities in substrate binding.

Authors:  Heidi Koldsø; Anja B Christiansen; Steffen Sinning; Birgit Schiøtt
Journal:  ACS Chem Neurosci       Date:  2012-11-08       Impact factor: 4.418

8.  The role of cysteines and histidins of the norepinephrine transporter.

Authors:  Birger Wenge; Heinz Bönisch
Journal:  Neurochem Res       Date:  2013-03-23       Impact factor: 3.996

9.  The persistent membrane retention of desipramine causes lasting inhibition of norepinephrine transporter function.

Authors:  Meng-Yang Zhu; Patrick B Kyle; Arthur S Hume; Gregory A Ordway
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

10.  N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic.

Authors:  Rina Glozman; Tsukasa Okiyoneda; Cory M Mulvihill; James M Rini; Herve Barriere; Gergely L Lukacs
Journal:  J Cell Biol       Date:  2009-03-23       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.